glp 1 trials GLP-1 Drug Pipeline 2026 Emerging Frontiers in GLP-1 Therapeutics:
Description
How common is it for employer-sponsored plans to cover GLP-1 drug for weight loss
Clinical data shows average weight loss of about 510% of total body weight over 12 weeks
Gier et al
In myocardial infarction (MI), infarct size is the most determinant cause of morbidity and mortality (1)
So theres good reason for skepticism
In the next five years, as these advanced drugs enter the market, Richards predicts that people and their doctors could effectively choose the exact weight they desireand that is a scary concept.
